These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37021513)

  • 1. Simultaneous quantification of (E) and (Z) isomers of rilpivirine and four degradation products in bulk and tablets by reversed-phase ultra-high-performance liquid chromatography and confirmation of all by molecular weight.
    Mhaske DK; Kumbhar AS
    J Sep Sci; 2023 Jul; 46(13):e2201067. PubMed ID: 37021513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impurity profile analysis of amphotericin B using on-line two-dimensional high performance liquid chromatography-quadrupole time-of-flight mass spectrometry].
    Weng RW; Wang XT; Wen HL; Liu H
    Se Pu; 2024 Apr; 42(5):432-444. PubMed ID: 38736386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma.
    Bevers LAH; van Ewijk-Beneken Kolmer EWJ; Te Brake HML; Burger DM
    J Pharm Biomed Anal; 2024 Jan; 238():115832. PubMed ID: 37976991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The first RP-UHPLC method for simultaneous quantification of abiraterone acetate, its four degradants, and six specified process impurities and correct identification of all analytes based on molecular weight.
    Mhaske DK; Kumbhar AS
    J Pharm Biomed Anal; 2023 Sep; 234():115568. PubMed ID: 37453147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography separation and identification of new oxidative degradation impurity in edoxaban tosylate hydrate drug substance by using liquid chromatography with tandem mass spectrometry.
    Alluri C; Sharma GVR
    Eur J Mass Spectrom (Chichester); 2023 Jun; 29(3):143-158. PubMed ID: 37306261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
    Vojta J; Jedlička A; Coufal P; Janečková L
    J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated stability-indicating ultra performance liquid chromatography method for the determination of potential process-related impurities in eplerenone.
    Du M; Pan C; Chen J; Song M; Zhu T; Hang T
    J Sep Sci; 2016 Aug; 39(15):2907-18. PubMed ID: 27256957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reversed-phase liquid chromatography separation and mass spectrometry fragmentation analysis of mitiglinide and three isomers].
    Li M; Liu H; Hou J; Wang C; Li W; Che B
    Se Pu; 2019 Apr; 37(4):412-417. PubMed ID: 30977344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid method for the simultaneous determination of L-ascorbic acid and acetylsalicylic acid in aspirin C effervescent tablet by ultra performance liquid chromatography-tandem mass spectrometry.
    Wabaidur SM; Alothman ZA; Khan MR
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 May; 108():20-5. PubMed ID: 23454710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of Prothionamide degradation impurities by mass spectrometry, NMR spectroscopy, and ultra high performance liquid chromatography method development.
    Baksam VK; Saritha N; Mohan SK; Shandilya S; Kumar P
    J Sep Sci; 2021 May; 44(10):2078-2088. PubMed ID: 33733566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Separation and identification of impurities from intermediates of istradefylline].
    Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M
    Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability-indicating liquid chromatography method development and validation for impurity profiling of montelukast sodium in bulk drug and tablet dosage form.
    Pasham M; Haridasyam SB; Boppy NVVDP; Venkatanarayana M; Palakurthi AK
    Biomed Chromatogr; 2022 Apr; 36(4):e5330. PubMed ID: 34994006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability-indicating liquid chromatography method development for assay and impurity profiling of amitriptyline hydrochloride in tablet dosage form and forced degradation study.
    Boppy NVVDP; Haridasyam SB; Vadagam N; Pasham M; Venkatanarayana M; Begum B
    Biomed Chromatogr; 2022 Oct; 36(10):e5436. PubMed ID: 35766584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an analytical method for the determination of pimavanserin and its impurities applying analytical quality by design principles as a risk-based strategy.
    Radić I; Runje M; Babić S
    J Pharm Biomed Anal; 2021 Jul; 201():114091. PubMed ID: 33964725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A validated ultra high-pressure liquid chromatography method for separation of candesartan cilexetil impurities and its degradents in drug product.
    Kumar ND; Babu KS; Gosada U; Sharma N
    Pharm Methods; 2012 Jan; 3(1):31-9. PubMed ID: 23781475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an analytical method for trace-level quantification of genotoxic nitrosamine impurities in losartan and hydrochlorothiazide fixed-dose combination tablets using ultra performance liquid chromatography triple quadrupole mass spectrometry.
    Patel R; Purohit S; Solanki R; Khunt D; Patel C; Patel R; Parikh S
    Rapid Commun Mass Spectrom; 2023 Apr; 37(8):e9488. PubMed ID: 36740827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.